Pharmacokinetics of ertapenem in healthy young volunteers.

Authors

• A K Majumdar
• D G Musson
• K L Birk
• C J Kitchen
• S Holland
• J McCrea
• G Mistry
• M Hesney
• L Xi
• S X Li
• R Haesen
• R A Blum
• R L Lins
• H Greenberg
• S Waldman
• P Deutsch
• J D Rogers

Publication/Presentation Date

11-1-2002

Abstract

Ertapenem (INVANZ) is a new once-a-day parenteral beta-lactam antimicrobial shown to be effective as a single agent for treatment of various community-acquired and mixed infections. The single- and multiple-dose pharmacokinetics of ertapenem at doses up to 3 g were examined in healthy young men and women volunteers. Plasma and urine samples collected were analyzed using reversed-phase high-performance liquid chromatography with UV detection. Ertapenem is highly bound to plasma protein. The protein binding changes from approximately 95% bound at concentrations of < 50 micro g/ml to approximately 92% bound at concentrations of 150 micro g/ml (concentration at the end of a 30-min infusion following the 1-g dose). The nonlinear protein binding of ertapenem resulted in a slightly less than dose proportional increase in the area under the curve from 0 h to infinity (AUC(0- infinity )) of total ertapenem. The single-dose AUC(0- infinity ) of unbound ertapenem was nearly dose proportional over the dose range of 0.5 to 2 g. The mean concentration of ertapenem in plasma ranged from approximately 145 to 175 micro g/ml at the end of a 30-min infusion, from approximately 30 to 34 micro g/ml at 6 h, and from approximately 9 to 11 micro g/ml at 12 h. The mean plasma t(1/2) ranged from 3.8 to 4.4 h. About 45% of the plasma clearance (CL(P)) was via renal clearance. The remainder of the CL(P) was primarily via the formation of the beta-lactam ring-opened metabolite that was excreted in urine. There were no clinically significant differences between the pharmacokinetics of ertapenem in men and women. Ertapenem does not accumulate after multiple once-daily dosing.

Volume

46

Issue

11

First Page

3506

Last Page

3511

ISSN

0066-4804

Published In/Presented At

Majumdar, A. K., Musson, D. G., Birk, K. L., Kitchen, C. J., Holland, S., McCrea, J., Mistry, G., Hesney, M., Xi, L., Li, S. X., Haesen, R., Blum, R. A., Lins, R. L., Greenberg, H., Waldman, S., Deutsch, P., & Rogers, J. D. (2002). Pharmacokinetics of ertapenem in healthy young volunteers. Antimicrobial agents and chemotherapy, 46(11), 3506–3511. https://doi.org/10.1128/AAC.46.11.3506-3511.2002

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

12384357

Department(s)

Administration and Leadership

Document Type

Article